CVRx (CVRX) Stock Forecast, Price Target & Predictions
CVRX Stock Forecast
CVRx stock forecast is as follows: an average price target of $15.83 (represents a 101.66% upside from CVRX’s last price of $7.85) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
CVRX Price Target
The average price target for CVRx (CVRX) is $15.83 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $23.00 to $12.00. This represents a potential 101.66% upside from CVRX's last price of $7.85.
CVRX Analyst Ratings
According to 6 Wall Street analysts, CVRx's rating consensus is 'Buy'. The analyst rating breakdown for CVRX stock is 0 'Strong Buy' (0.00%), 4 'Buy' (66.67%), 2 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
CVRx Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | Ross Osborn | Cantor Fitzgerald | $14.00 | $7.96 | 75.88% | 78.34% |
| Jul 30, 2024 | Matt O'Brien | Piper Sandler | $13.00 | $9.27 | 40.24% | 65.61% |
| Jul 30, 2024 | William Plovanic | Canaccord Genuity | $15.00 | $9.27 | 61.81% | 91.08% |
| Jul 11, 2024 | Frank Takkinen | Lake Street | $12.00 | $7.59 | 58.10% | 52.87% |
| Jun 05, 2024 | Frank Takkinen | Loop Capital Markets | $18.00 | $8.00 | 125.14% | 129.30% |
| May 01, 2024 | Chase Knickerbocker | Craig-Hallum | $23.00 | $9.27 | 148.11% | 192.99% |
The latest CVRx stock forecast, released on Sep 10, 2024 by Ross Osborn from Cantor Fitzgerald, set a price target of $14.00, which represents a 75.88% increase from the stock price at the time of the forecast ($7.96), and a 78.34% increase from CVRX last price ($7.85).
CVRx Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 4 | 6 |
| Avg Price Target | $14.00 | $13.50 | $15.83 |
| Last Closing Price | $7.85 | $7.85 | $7.85 |
| Upside/Downside | 78.34% | 71.97% | 101.66% |
In the current month, the average price target of CVRx stock is $14.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 78.34% increase as opposed to CVRx's last price of $7.85. This month's average price target is up 3.70% compared to last quarter, and down -11.56% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 10, 2024 | Cantor Fitzgerald | - | Overweight | Initialise |
| Aug 26, 2024 | Piper Sandler | Buy | Buy | Hold |
| Jul 30, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jul 30, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Jul 11, 2024 | Lake Street | Buy | Buy | Hold |
| Jun 05, 2024 | Lake Street | Buy | Buy | Hold |
| May 01, 2024 | William Blair | - | Market Perform | Downgrade |
| Dec 27, 2023 | Lake Street | Buy | Buy | Hold |
| Feb 07, 2023 | Canaccord Genuity | Buy | Buy | Hold |
| Jan 09, 2023 | Piper Sandler | Overweight | Overweight | Hold |
CVRx's last stock rating was published by Cantor Fitzgerald on Sep 10, 2024. The company Initialise its CVRX rating from "null" to "Overweight".
CVRx Financial Forecast
CVRx Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $10.51M | $9.50M | $7.98M | $7.18M | $6.19M | - | $4.08M | $3.66M | $3.40M | $3.12M |
| Avg Forecast | $23.61M | $21.71M | $19.93M | $18.05M | $18.26M | $17.02M | $16.04M | $14.65M | $14.77M | $13.21M | $11.80M | $11.42M | $11.14M | $9.82M | $8.59M | $7.20M | $6.97M | $5.72M | $4.70M | $3.79M | $3.88M | $3.29M | $2.83M |
| High Forecast | $25.04M | $23.02M | $21.13M | $19.14M | $19.37M | $18.05M | $17.01M | $15.53M | $15.66M | $13.55M | $12.51M | $12.12M | $11.82M | $10.10M | $9.11M | $7.64M | $7.39M | $6.07M | $4.70M | $3.93M | $4.03M | $3.41M | $2.94M |
| Low Forecast | $22.72M | $20.88M | $19.17M | $17.36M | $17.57M | $16.38M | $15.43M | $14.09M | $14.21M | $12.95M | $11.35M | $10.99M | $10.72M | $9.50M | $8.26M | $6.93M | $6.71M | $5.50M | $4.70M | $3.63M | $3.72M | $3.15M | $2.71M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | - | 1 | 6 | 3 | 3 | 4 | 4 | 2 | 2 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.11% | 1.11% | 1.03% | 1.08% | - | 1.08% | 0.94% | 1.03% | 1.10% |
CVRx's average Quarter revenue forecast for Dec 23 based on 1 analysts is $11.14M, with a low forecast of $10.72M, and a high forecast of $11.82M. CVRX's average Quarter revenue forecast represents a 6.02% increase compared to the company's last Quarter revenue of $10.51M (Sep 23).
CVRx EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | - | 1 | 6 | 3 | 3 | 4 | 4 | 2 | 2 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-8.47M | $-11.14M | $-11.10M | $-10.34M | $-9.80M | - | $-9.96M | $-10.09M | $-5.45M | $-17.08M |
| Avg Forecast | $-23.61M | $-21.71M | $-19.93M | $-18.05M | $-18.26M | $-17.02M | $-16.04M | $-14.65M | $-14.77M | $-13.21M | $-11.80M | $-11.98M | $-11.14M | $-9.82M | $-8.59M | $-10.89M | $-6.97M | $-8.35M | $-4.70M | $-9.90M | $-7.98M | $-6.60M | $-9.45M |
| High Forecast | $-22.72M | $-20.88M | $-19.17M | $-17.36M | $-17.57M | $-16.38M | $-15.43M | $-14.09M | $-14.21M | $-12.95M | $-11.35M | $-9.59M | $-10.72M | $-9.50M | $-8.26M | $-8.71M | $-6.71M | $-6.68M | $-4.70M | $-7.92M | $-6.38M | $-5.28M | $-7.56M |
| Low Forecast | $-25.04M | $-23.02M | $-21.13M | $-19.14M | $-19.37M | $-18.05M | $-17.01M | $-15.53M | $-15.66M | $-13.55M | $-12.51M | $-14.38M | $-11.82M | $-10.10M | $-9.11M | $-13.07M | $-7.39M | $-10.02M | $-4.70M | $-11.88M | $-9.58M | $-7.92M | $-11.34M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.86% | 1.30% | 1.02% | 1.48% | 1.17% | - | 1.01% | 1.26% | 0.83% | 1.81% |
undefined analysts predict CVRX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than CVRx's previous annual EBITDA (undefined) of $NaN.
CVRx Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | - | 1 | 6 | 3 | 3 | 4 | 4 | 2 | 2 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-9.01M | $-11.65M | $-11.37M | $-10.54M | $-9.83M | - | $-9.99M | $-10.57M | $-6.13M | $-17.75M |
| Avg Forecast | $-8.54M | $-8.33M | $-8.00M | $-8.54M | $-10.11M | $-10.69M | $-10.93M | $-10.78M | $-9.69M | $-10.15M | $-11.82M | $-12.09M | $-11.78M | $-12.51M | $-12.61M | $-10.99M | $-12.01M | $-9.39M | $-11.30M | $-9.99M | $-8.36M | $-7.42M | $-9.82M |
| High Forecast | $-8.12M | $-7.92M | $-7.61M | $-8.12M | $-9.61M | $-10.16M | $-10.39M | $-10.25M | $-9.21M | $-9.47M | $-11.23M | $-9.67M | $-11.13M | $-11.65M | $-11.99M | $-8.79M | $-11.42M | $-7.51M | $-11.30M | $-7.99M | $-6.69M | $-5.94M | $-7.85M |
| Low Forecast | $-9.22M | $-8.98M | $-8.63M | $-9.22M | $-10.90M | $-11.53M | $-11.79M | $-11.63M | $-10.45M | $-10.60M | $-12.75M | $-14.51M | $-12.20M | $-13.16M | $-13.61M | $-13.19M | $-12.95M | $-11.27M | $-11.30M | $-11.99M | $-10.03M | $-8.91M | $-11.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.72% | 0.92% | 1.03% | 0.88% | 1.05% | - | 1.00% | 1.26% | 0.83% | 1.81% |
CVRx's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CVRX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
CVRx SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | - | 1 | 6 | 3 | 3 | 4 | 4 | 2 | 2 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $15.65M | $16.45M | $15.40M | $14.10M | $12.68M | - | $10.78M | $9.66M | $8.11M | $5.63M |
| Avg Forecast | $40.56M | $37.28M | $34.22M | $30.99M | $31.37M | $29.24M | $27.55M | $25.15M | $25.36M | $22.69M | $20.26M | $19.62M | $19.14M | $16.87M | $14.74M | $12.37M | $11.97M | $9.82M | $8.07M | $6.51M | $6.67M | $5.65M | $4.86M |
| High Forecast | $43.01M | $39.54M | $36.30M | $32.87M | $33.27M | $31.01M | $29.22M | $26.68M | $26.90M | $23.27M | $21.49M | $20.81M | $20.30M | $17.36M | $15.64M | $13.12M | $12.70M | $10.42M | $8.07M | $6.75M | $6.92M | $5.86M | $5.04M |
| Low Forecast | $39.02M | $35.87M | $32.93M | $29.82M | $30.18M | $28.13M | $26.51M | $24.20M | $24.40M | $22.24M | $19.49M | $18.88M | $18.41M | $16.32M | $14.19M | $11.90M | $11.52M | $9.45M | $8.07M | $6.24M | $6.39M | $5.41M | $4.66M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | 1.12% | 1.25% | 1.18% | 1.29% | - | 1.66% | 1.45% | 1.44% | 1.16% |
CVRx's average Quarter SG&A projection for Dec 23 is $19.14M, based on 1 Wall Street analysts, with a range of $18.41M to $20.30M. The forecast indicates a 22.28% rise compared to CVRX last annual SG&A of $15.65M (Sep 23).
CVRx EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | - | 1 | 6 | 3 | 3 | 4 | 4 | 2 | 2 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | - | $-0.49 | $-0.52 | $-0.30 | $-0.88 |
| Avg Forecast | $-0.40 | $-0.39 | $-0.37 | $-0.40 | $-0.47 | $-0.49 | $-0.51 | $-0.50 | $-0.45 | $-0.47 | $-0.55 | $-0.54 | $-0.54 | $-0.58 | $-0.58 | $-0.57 | $-0.56 | $-0.55 | $-0.53 | $-0.49 | $-0.45 | $-0.38 | $-0.64 |
| High Forecast | $-0.38 | $-0.37 | $-0.35 | $-0.38 | $-0.44 | $-0.47 | $-0.48 | $-0.47 | $-0.43 | $-0.44 | $-0.52 | $-0.51 | $-0.51 | $-0.54 | $-0.55 | $-0.54 | $-0.53 | $-0.52 | $-0.53 | $-0.46 | $-0.42 | $-0.36 | $-0.61 |
| Low Forecast | $-0.43 | $-0.42 | $-0.40 | $-0.43 | $-0.50 | $-0.53 | $-0.55 | $-0.54 | $-0.48 | $-0.49 | $-0.59 | $-0.58 | $-0.56 | $-0.61 | $-0.63 | $-0.61 | $-0.60 | $-0.59 | $-0.53 | $-0.51 | $-0.47 | $-0.40 | $-0.67 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.74% | 0.96% | 0.97% | 0.92% | 0.88% | - | 1.00% | 1.17% | 0.78% | 1.38% |
According to undefined Wall Street analysts, CVRx's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CVRX previous annual EPS of $NaN (undefined).
CVRx Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CVRX | CVRx | $7.85 | $15.83 | 101.66% | Buy |
| OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| SGHT | Sight Sciences | $6.95 | $10.33 | 48.63% | Hold |
| LUNG | Pulmonx | $8.31 | $12.25 | 47.41% | Buy |
| LIVN | LivaNova | $48.53 | $71.25 | 46.82% | Buy |
| KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
| AORT | Artivion | $25.25 | $30.00 | 18.81% | Buy |
| SRDX | Surmodics | $39.36 | $39.50 | 0.36% | Buy |
CVRX Forecast FAQ
Is CVRx a good buy?
Yes, according to 6 Wall Street analysts, CVRx (CVRX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 66.67% of CVRX's total ratings.
What is CVRX's price target?
CVRx (CVRX) average price target is $15.83 with a range of $12 to $23, implying a 101.66% from its last price of $7.85. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will CVRx stock go up soon?
According to Wall Street analysts' prediction for CVRX stock, the company can go up by 101.66% (from the last price of $7.85 to the average price target of $15.83), up by 192.99% based on the highest stock price target, and up by 52.87% based on the lowest stock price target.
Can CVRx stock reach $12?
CVRX's average twelve months analyst stock price target of $15.83 supports the claim that CVRx can reach $12 in the near future.
What is CVRx's current price target trend?
1 Wall Street analyst forecast a $14 price target for CVRx (CVRX) this month, up 78.34% from its last price of $7.85. Compared to the last 3 and 12 months, the average price target increased by 71.97% and increased by 101.66%, respectively.
What are CVRx's analysts' financial forecasts?
CVRx's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $65.97M (high $69.97M, low $63.48M), average EBITDA is $-65.975M (high $-63.476M, low $-69.973M), average net income is $-42.509M (high $-40.416M, low $-45.858M), average SG&A $113.31M (high $120.18M, low $109.02M), and average EPS is $-1.965 (high $-1.869, low $-2.12). CVRX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $83.29M (high $88.34M, low $80.14M), average EBITDA is $-83.29M (high $-80.136M, low $-88.338M), average net income is $-33.416M (high $-31.771M, low $-36.049M), average SG&A $143.05M (high $151.72M, low $137.63M), and average EPS is $-1.545 (high $-1.469, low $-1.667).
Did the CVRX's actual financial results beat the analysts' financial forecasts?
Based on CVRx's last annual report (Dec 2023), the company's revenue was $39.3M, beating the average analysts forecast of $36.75M by 6.91%. Apple's EBITDA was $-43.103M, beating the average prediction of $-40.447M by 6.57%. The company's net income was $-41.199M, missing the average estimation of $-47.886M by -13.96%. Apple's SG&A was $64.51M, beating the average forecast of $63.12M by 2.19%. Lastly, the company's EPS was $-0.002, missing the average prediction of $-2.272 by -99.91%. In terms of the last quarterly report (Sep 2023), CVRx's revenue was $10.51M, beating the average analysts' forecast of $9.82M by 6.99%. The company's EBITDA was $-8.472M, missing the average prediction of $-9.825M by -13.77%. CVRx's net income was $-9.011M, missing the average estimation of $-12.508M by -27.96%. The company's SG&A was $15.65M, missing the average forecast of $16.87M by -7.24%. Lastly, the company's EPS was $-0.43, missing the average prediction of $-0.578 by -25.65%